MARY PALECEK: Open Payments
NPI 1801806526 · LINDALE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 7 payments from 5 companies in 2025. Trend: 2023 $110 · 2024 $87 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $61 |
| ABBVIE INC. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| UCB, Inc. | 1 | $19 |
Products named: KEVZARA, SKYRIZI, RINVOQ, COSENTYX, LUPKYNIS, Bimzelx.
Industry payments across TX — which companies pay providers there.
